Your browser doesn't support javascript.
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.
Weinkove, Robert; McQuilten, Zoe K; Adler, Jonathan; Agar, Meera R; Blyth, Emily; Cheng, Allen C; Conyers, Rachel; Haeusler, Gabrielle M; Hardie, Claire; Jackson, Christopher; Lane, Steven W; Middlemiss, Tom; Mollee, Peter; Mulligan, Stephen P; Ritchie, David; Ruka, Myra; Solomon, Benjamin; Szer, Jeffrey; Thursky, Karin A; Wood, Erica M; Worth, Leon J; Yong, Michelle K; Slavin, Monica A; Teh, Benjamin W.
  • Weinkove R; Wellington Blood and Cancer Centre, Capital and Coast District Health Board, Wellington, NZ.
  • McQuilten ZK; Malaghan Institute of Medical Research, Wellington, NZ.
  • Adler J; Monash University, Melbourne, VIC.
  • Agar MR; Monash Health, Melbourne, VIC.
  • Blyth E; Wellington Regional Hospital, Capital and Coast District Health Board, Wellington, NZ.
  • Cheng AC; Improving Palliative, Aged and Chronic Care through Clinical Research and Translation, University of Technology, Sydney, NSW.
  • Conyers R; Westmead Hospital, Sydney, NSW.
  • Haeusler GM; Westmead Institute for Medical Research, Sydney, NSW.
  • Hardie C; Monash University, Melbourne, VIC.
  • Jackson C; Children's Cancer Centre, Royal Children's Hospital, Melbourne, VIC.
  • Lane SW; Murdoch Children's Research Institute, Melbourne, VIC.
  • Middlemiss T; Peter MacCallum Cancer Centre, Melbourne, VIC.
  • Mollee P; Royal Children's Hospital, Melbourne, VIC.
  • Mulligan SP; MidCentral District Health Board, Palmerston North, NZ.
  • Ritchie D; Cancer Society of New Zealand, Wellington, NZ.
  • Ruka M; University of Otago, Dunedin, NZ.
  • Solomon B; Royal Brisbane and Women's Hospital, Brisbane, QLD.
  • Szer J; Te Omanga Hospice, Lower Hutt, NZ.
  • Thursky KA; Princess Alexandra Hospital, Brisbane, QLD.
  • Wood EM; University of Queensland, Brisbane, QLD.
  • Worth LJ; Royal North Shore Hospital, Sydney, NSW.
  • Yong MK; Royal Melbourne Hospital, Melbourne, VIC.
  • Slavin MA; Waikato District Health Board, Hamilton, NZ.
  • Teh BW; University of Auckland, Auckland, NZ.
Med J Aust ; 212(10): 481-489, 2020 06.
Article in English | MEDLINE | ID: covidwho-245741
ABSTRACT

INTRODUCTION:

A pandemic coronavirus, SARS-CoV-2, causes COVID-19, a potentially life-threatening respiratory disease. Patients with cancer may have compromised immunity due to their malignancy and/or treatment, and may be at elevated risk of severe COVID-19. Community transmission of COVID-19 could overwhelm health care services, compromising delivery of cancer care. This interim consensus guidance provides advice for clinicians managing patients with cancer during the pandemic. MAIN

RECOMMENDATIONS:

During the COVID-19 pandemic In patients with cancer with fever and/or respiratory symptoms, consider causes in addition to COVID-19, including other infections and therapy-related pneumonitis. For suspected or confirmed COVID-19, discuss temporary cessation of cancer therapy with a relevant specialist. Provide information on COVID-19 for patients and carers. Adopt measures within cancer centres to reduce risk of nosocomial SARS-CoV-2 acquisition; support population-wide social distancing; reduce demand on acute services; ensure adequate staffing; and provide culturally safe care. Measures should be equitable, transparent and proportionate to the COVID-19 threat. Consider the risks and benefits of modifying cancer therapies due to COVID-19. Communicate treatment modifications, and review once health service capacity allows. Consider potential impacts of COVID-19 on the blood supply and availability of stem cell donors. Discuss and document goals of care, and involve palliative care services in contingency planning. CHANGES IN MANAGEMENT AS A RESULT OF THIS STATEMENT This interim consensus guidance provides a framework for clinicians managing patients with cancer during the COVID-19 pandemic. In view of the rapidly changing situation, clinicians must also monitor national, state, local and institutional policies, which will take precedence. ENDORSED BY Australasian Leukaemia and Lymphoma Group; Australasian Lung Cancer Trials Group; Australian and New Zealand Children's Haematology/Oncology Group; Australia and New Zealand Society of Palliative Medicine; Australasian Society for Infectious Diseases; Bone Marrow Transplantation Society of Australia and New Zealand; Cancer Council Australia; Cancer Nurses Society of Australia; Cancer Society of New Zealand; Clinical Oncology Society of Australia; Haematology Society of Australia and New Zealand; National Centre for Infections in Cancer; New Zealand Cancer Control Agency; New Zealand Society for Oncology; and Palliative Care Australia.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Practice Guidelines as Topic / Coronavirus Infections / Betacoronavirus / Hematology / Medical Oncology Type of study: Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Oceania Language: English Journal: Med J Aust Year: 2020 Document Type: Article Affiliation country: Mja2.50607

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Practice Guidelines as Topic / Coronavirus Infections / Betacoronavirus / Hematology / Medical Oncology Type of study: Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Oceania Language: English Journal: Med J Aust Year: 2020 Document Type: Article Affiliation country: Mja2.50607